Current knowledge and research priorities in central sleep apnoea
Symposium Chairs: S. Schiza (Heraklion, Greece), I. Rosenzweig (London, United Kingdom)
Aims: To provide an update on treatment options for CSA according to its pathogenesis. To explore new treatment options such as nerve stimulation and pharmacotherapy.
Introduction S. Schiza (Heraklion, Greece), I. Rosenzweig (London, United Kingdom)
|  |
What makes a difference? How to diagnose and characterise CSA W. Randerath (Solingen, Germany)
|   |
Current practice and future directions in CSA treatment: positive airway pressure, stimulation and pharmacotherapy M. Arzt (Regensburg, Germany)
|   |
Pharmacotherapy of CSA: who, when and how? S. Javaheri (Cincinnati, United States of America)
|   |
Discussion and Q&A W. Randerath (Solingen, Germany), M. Arzt (Regensburg, Germany), S. Javaheri (Cincinnati, United States of America), S. Schiza (Heraklion, Greece), I. Rosenzweig (London, United Kingdom)
|  |